In the next Front Row lecture, Darrell Irvine explains how controlling where vaccine components travel in the body, and when and for how long they’re delivered, can lead to stronger, longer-lasting immune responses. Hear how two approaches from his lab, a new vaccine adjuvant and a gradual dosing strategy, are moving into clinical testing. Grab a seat for November 18!
Professor Adjunct
Department of Molecular and Cellular Biology
New genetic links found to rare eye disease, opening the door to better diagnostics and potential treatments
The gene mutations explain why patients with MacTel are unable to produce enough of an amino acid needed for eye health.